Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Collegium Pharmaceutical, Inc. (NASDAQ: COLL)
COLL Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
4.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
78.70%
COLL Stock Analysis
COLL
PE Ratio:
15.3
COLL
PEG Ratio:
-20.3
COLL
Forward EPS Growth (12 month):
-0.80%
COLL
PS Ratio:
1.3
COLL
PSG Ratio:
0.4
COLL
Forward Revenue Growth (12 month):
3.40%
COLL Articles
No data was found